The role of microglia in central nervous system immunity and glioma immunology
Open accessAbstract
The central nervous system (CNS) historically has been considered an immune-privileged organ, lacking a lymphatic system and shielded from the circulatory system by the blood-brain barrier. Microglia are an abundant portion of the CNS cell population, comprising 5% to 20% of the total glial cell population, and are as numerous as neurons. A crucial function of microglia is the ability to generate significant innate and adaptive immune responses. Microglia are involved in first line innate immunity of the CNS. Proper antigen presentation is critical in the generation of specific, durable responses by the adaptive immune system, and requires interaction between the T cell receptor and processed antigen peptide presented on major histocompatibility complex (MHC) molecules by the antigen presenting cells (APC). Microglia also have a large regulatory role in CNS immunity. Histopathologic studies of glioma tissue have consistently shown high levels of infiltrating microglia. Microglia are also localized diffusely throughout the tumor, rather than to the areas of necrosis, and phagocytosis of glioma cells or debris by microglia is not observed. Recent evidence indicates that glioma-infiltrating microglia/macrophages might be promoting tumor growth by facilitating immunosuppression of the tumor microenvironment. When activated, microglia can be potent immune effector cells, able to perform a broad range of functions, and they mediate both innate and adaptive responses during CNS injury and disease while remaining quiescent in the steady state. Their versatility in bridging the gap between the immune-privileged CNS and the peripheral immune system, in addition to their significant numbers in gliomas, makes them an attractive candidate in immunotherapy for gliomas. An enhanced understanding of microglia-glioma interaction may provide better methods to manipulate the glioma microenvironment to allow the generation of a specific and durable anti-glioma immunity. The role of microglia in CNS immunity is reviewed, with a focus on key advances made in glioma immunology.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Microglia are the resident mononuclear phagocytes of the CNS and play key roles in immune surveillance and defense, synaptic remodeling, and homeostasis.
“Microglia, the resident mononuclear phagocytes of the CNS, play key roles in immune surveillance and defense [39], synaptic remodeling [40], and homeostasis [41].”
From Untangling senescent and damage‐associated microglia in the aging and diseased brain (2023) · cites this paper as [39]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1× · see citing works
“As routine surveillance of the CNS, microglia, even in their quiescent form, continually monitor their microenvironment through pinocytosis and interaction with neurons [29].”
BackgroundTumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025 · see citing works
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1× · see citing works
“Resting microglia serve as poor APC [59]; however, activating stimuli induce microglia to robustly increase their expression of MHC [60] and costimulatory molecules [61].”
BackgroundHeterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · see citing works
van Kooten, C., & Banchereau, J. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.2 · Cited by 1,413 · cited 3× · see citing works
“The CD40–CD40L interaction also induces microglia to increase the release of nitric synthase [56].”
BackgroundLoss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1517 · Cited by 1,341 · cited 1× · see citing works
“In normal brain, microglia express B7-H1, a potent immunosuppressive molecule that induces T cell apoptosis [93, 94].”
BackgroundSelf-citationMicroglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
Olson, J. K., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3916 · Cited by 1,215 · cited 4× · see citing works
“Mature microglia express a variety of macrophage-specific markers including Toll-like receptors (TLR) [22, 23], the integrin CD11b [24], and the glycoprotein of unknown function, F4/80.”
BackgroundInfluentialMicroglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,111 · cited 1× · see citing works
“MHC molecules are generally restricted to microglia in low levels [6, 57, 58].”
BackgroundCytology & cellular pathology of the nervous system
Penfield, W. G. (1965) · Medical Entomology and Zoology · Cited by 1,035 · see citing works
Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)
Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022 · cited 3× · see citing works
“Upon activation, microglia upregulate opsonic receptors including complement receptors (CR1, CR3, CR4) and Fc gamma receptors (I, II, III), which enhance phagocytic activity by binding to complement components and immunoglobulin fragments respectively [50, 51].”
BackgroundBanati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,020 · cited 1× · see citing works
“For example, microglia express TLR [22] and initiate innate responses with the production of cytokines, chemokines and nitric oxide (NO) [37, 38].”
BackgroundBroad Expression of Toll-Like Receptors in the Human Central Nervous System
Bsibsi, M., Ravid, R., Gveric, D. O., & van Noort, J. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.11.1013 · Cited by 1,000 · cited 4× · see citing works
“Mature microglia express a variety of macrophage-specific markers including Toll-like receptors (TLR) [22, 23], the integrin CD11b [24], and the glycoprotein of unknown function, F4/80.”
BackgroundInfluentialMicroglial Activation and its Implications in the Brain Diseases
Dheen, S. T., Kaur, C., & Ling, E. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597961 · Cited by 954 · cited 1× · see citing works
“The resting ramified microglia cells are activated by a variety of CNS pathologies, such as infection, injury, and neurodegenerative disease, by detecting lipopolysaccharide (LPS), beta-amyloid (Aβ), thrombin, IFN-γ, and other proinflammatory cytokines [36].”
BackgroundMolecular mechanisms of glioma invasiveness: the role of proteases
Rao, J. S. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1121 · Cited by 847 · cited 1× · see citing works
“Their release into the tumor environment can help increase the spread of tumors by paving the road for proliferation of tumor cells [81].”
BackgroundTurnover of resident microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., & Gordon, S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90500-2 · Cited by 709 · see citing works
Sedgwick, J. D., Schwender, S., Imrich, H., Dörries, R., Butcher, G. W., & ter Meulen, V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7438 · Cited by 691 · see citing works
The origin and nature of ramified and amoeboid microglia: A historical review and current concepts
Ling, E., & Wong, W.-C. (1993) · Glia · doi:10.1002/glia.440070105 · Cited by 690 · cited 2× · see citing works
“Microglia are classified according their morphology into three types: resting ramified, activated, and amoeboid phagocytic [21].”
BackgroundErratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomão, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm0902-1039c · Cited by 545 · see citing works
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
Benveniste, E. N. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050101 · Cited by 532 · see citing works
Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS
Babcock, A. A., Kuziel, W. A., Rivest, S., & Owens, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07922.2003 · Cited by 472 · cited 2× · see citing works
“MCP-1 is produced by glioma cells, and microglia express a specific MCP-1 receptor, CCR2 [75, 76].”
BackgroundBrain microglia constitutively express β-2 integrins
Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90055-r · Cited by 430 · cited 2× · see citing works
“Dick AD, Ford AL, Forrester JV, et al. Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia.”
Brain Dendritic Cells and Macrophages/Microglia in Central Nervous System Inflammation
Fischer, H., & Reichmann, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2717 · Cited by 408 · cited 1× · see citing works
“Fischer and Reichmann have demonstrated that in vitro incubation of purified microglia with GM-CSF increases microglia cell size and induces a heterogeneous population that contains cells resembling other tissue macrophages [35].”
BackgroundWright, G. J., Puklavec, M. J., Willis, A. C., Hoek, R. M., Sedgwick, J. D., Brown, M. H., & Barclay, A. N. (2000) · Immunity · doi:10.1016/s1074-7613(00)00023-6 · Cited by 388 · cited 1× · see citing works
“In addition, Hoek and colleagues have implicated a membrane-bound glycoprotein, OX2 or CD200, expressed on neurons as a key regulator of microglia [32, 33].”
BackgroundSchilling, M., Besselmann, M., Leonhard, C., Mueller, M., Ringelstein, E. B., & Kiefer, R. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00082-7 · Cited by 375 · cited 1× · see citing works
“The specific sequence of events demonstrating that microglia activation precedes peripheral cell infiltration has been demonstrated in bone marrow chimeric mice in an elegant study by Schilling and colleagues [49].”
BackgroundKennedy, D. W., & Abkowitz, J. L. (1997) · Blood · doi:10.1182/blood.v90.3.986 · Cited by 342 · see citing works
Distribution and characterization of microglia/macrophages in human brain tumors
Roggendorf, W., Strupp, S., & Paulus, W. (1996) · Acta Neuropathologica · doi:10.1007/s004010050520 · Cited by 319 · see citing works
Ferrer, I., Bernet, E., Soriano, E., del Rı́o, J. A., & Fonseca, M. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90281-8 · Cited by 309 · cited 1× · see citing works
“Microglia also show transitory phagocytosis during CNS ontogeny to clear apoptotic neuronal cell bodies [52].”
BackgroundTransforming growth factor-beta suppresses activation and proliferation of microglia in vitro.
Suzumura, A., Sawada, M., Yamamoto, H., & Marunouchi, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2150 · Cited by 305 · cited 1× · see citing works
“In particular, TGF-β2 inhibits proliferation and secretion of proinflammatory cytokines by microglia and lymphocytes [92].”
BackgroundHematopoietic origin of microglial and perivascular cells in brain
Hess, D. C., Abe, T., Hill, W., Martin-Studdard, A., Carothers, J., Masuya, M., Fleming, P. A., Drake, C. J., & Ogawa, M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.11.005 · Cited by 281 · cited 2× · see citing works
“In the perinatal brain, the amoeboid phagocytic microglia are the predominant form [27].”
BackgroundTsai, J., Goldman, C. K., & Gillespie, G. Y. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.82.5.0864 · Cited by 278 · cited 3× · see citing works
“Lafuente JV, Adan B, Alkiza K, et al. Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas.”
BackgroundAloisi, F., Ria, F., Penna, G., & Adorini, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4671 · Cited by 276 · see citing works
Microglia induce CD4 T lymphocyte final effector function and death.
Ford, A. L., Foulcher, E., Lemckert, F. A., & Sedgwick, J. D. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.5.1737 · Cited by 260 · cited 8× · see citing works
“Proper antigen presentation is critical in the generation-specific durable responses by the adaptive immune system, and requires interaction between the T cell receptor and processed antigen peptide presented on MHC molecules by the APCs.”
BackgroundInfluentialFloden, A. M., Li, S., & Combs, C. K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4998-04.2005 · Cited by 246 · see citing works
Macrophages in experimental and human brain tumors
Morantz, R. A., Wood, G. W., Foster, M., Clark, M., & Gollahon, K. A. (1979) · Journal of neurosurgery · doi:10.3171/jns.1979.50.3.0305 · Cited by 239 · cited 1× · see citing works
“Historically, the recruitment of microglia in gliomas was postulated as evidence of the attempt by CNS to fend off dividing neoplastic cells [80].”
BackgroundThe central nervous system as an immunocompetent organ: role of glial cells in antigen presentation
Shrikant, P., & Benveniste, E. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1819 · Cited by 233 · cited 1× · see citing works
“Additionally, in vivo and in vitro studies have demonstrated that IFN-γ induces and maintains expression of MHC class II and adhesion/ costimulatory molecules on microglia to maintain T cell stimulation [62].”
BackgroundHöftberger, R., Aboul‐Enein, F., Brück, W., Lucchinetti, C. F., Rodriguez, M., Schmidbauer, M., Jellinger, K. A., & Lassmann, H. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00496.x · Cited by 229 · cited 1× · see citing works
“MHC molecules are generally restricted to microglia in low levels [6, 57, 58].”
BackgroundSimone, R. D., Giampaolo, A., Giometto, B., Gallo, P., Levi, G., Peschle, C., & Aloisi, F. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00004 · Cited by 201 · cited 1× · see citing works
“Resting microglia serve as poor APC [59]; however, activating stimuli induce microglia to robustly increase their expression of MHC [60] and costimulatory molecules [61].”
BackgroundCD28/CTLA-4 and CD80/CD86 families
Slavik, J. M., Hutchcroft, J. E., & Bierer, B. E. (1999) · Immunologic Research · doi:10.1007/bf02786473 · Cited by 194 · cited 2× · see citing works
“1, CD40, CD80, and CD86 expressed on the surface of APC and specific counter-receptors on T cells [55, 56].”
BackgroundRole of microglia in glioma biology
Badie, B., & Schartner, J. M. (2001) · Microscopy Research and Technique · doi:10.1002/jemt.1125 · Cited by 184 · cited 3× · see citing works
“Recent evidence indicates that glioma-infiltrating microglia/macrophages might be promoting tumor growth by facilitating immunosuppression of the tumor microenvironment [16].”
BackgroundInfluentialParney, I. F., Petruk, K. C., Hao, C., Roa, W., Turner, J., & Ramsay, D. A. (2002) · Acta Neuropathologica · doi:10.1007/s004010100448 · Cited by 181 · cited 3× · see citing works
“Microglia are also localized diffusely throughout the tumor, and not to the areas of necrosis, and phagocytosis of glioma cells or debris by microglia is not observed [1].”
BackgroundFlow cytometry and in vitro analysis of human glioma–associated macrophages
Parney, I. F., Waldron, J. S., & Parsa, A. T. (2009) · Journal of neurosurgery · doi:10.3171/2008.7.jns08475 · Cited by 174 · cited 2× · see citing works
“Co-culture of human peripheral blood mononuclear cells with human glioma lines caused glioma-conditioned monocytes to reduce phagocytic activity [84].”
BackgroundSelf-citationPhagocytic Response in Photochemically Induced Infarction of Rat Cerebral Cortex
Schroeter, M., Jander, S., Huitinga, I., Witte, O. W., & Stoll, G. (1997) · Stroke · doi:10.1161/01.str.28.2.382 · Cited by 169 · see citing works
Microglia promote glioma migration
Bettinger, I., Thanos, S., & Paulus, W. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0472-x · Cited by 165 · see citing works
Human Glioma-derived Interleukin-10 Inhibits Antitumor Immune Responses In Vitro
Hishii, M., Nitta, T., Ishida, H., Ebato, M., Kurosu, A., Yagita∥, H., Sato, K., & Okumura, K. (1995) · Neurosurgery · doi:10.1227/00006123-199512000-00016 · Cited by 160 · cited 1× · see citing works
“IL-10 in turn inhibits cytotoxic T cell function, further contributing to the immunoresistant phenotype of glioma cells [89].”
BackgroundMagnus, T., Schreiner, B., Korn, T., Jack, C. S., Guo, H., Antel, J. P., Ifergan, I., Chen, L., Bischof, F., Bar‐Or, A., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4794-04.2005 · Cited by 160 · cited 1× · see citing works
“In normal brain, microglia express B7-H1, a potent immunosuppressive molecule that induces T cell apoptosis [93, 94].”
BackgroundAloisi, F., Simone, R. D., Cabezas, S. C., Penna, G., & Adorini, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1705 · Cited by 153 · see citing works
Glioma Immunology and Immunotherapy
Parney, I. F., Hao, C., & Petruk, K. C. (2000) · Neurosurgery · doi:10.1097/00006123-200004000-00002 · Cited by 145 · cited 1× · see citing works
“Glioma cells produce anti-inflammatory cytokines such as IL-6 and TGF-β2 and PGE2 along with producing tumor growth promoting cytokines such as IL-1 and bFGF [1, 91].”
BackgroundNeuronal Control of MHC Class II Inducibility in Rat Astrocytes and Microglia
Neumann, H., Boucraut, J., Hahnel, C., Misgeld, T., & Wekerle, H. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01552.x · Cited by 143 · cited 6× · see citing works
“Additionally, in vivo and in vitro studies have demonstrated that IFN-γ induces and maintains expression of MHC class II and adhesion/ costimulatory molecules on microglia to maintain T cell stimulation [62].”
BackgroundInfluentialAstrocytic Regulation of Human Monocytic/Microglial Activation
Kostianovsky, A. M., Maier, L. M., Anderson, R. C. E., Bruce, J. N., & Anderson, D. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5425 · Cited by 142 · cited 2× · see citing works
“Kostianovsky and colleagues demonstrated in vitro that glioblastoma cells down regulated the production of the proinflammatory cytokine TNF-α by microglia when stimulated with LPS or β-amyloid [70].”
BackgroundSuccessful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.
Carpentier, A. F., Xie, J., Mokhtari, K., & Delattre, J. (2000) · PubMed · Cited by 138 · see citing works
Chan, S. L., Griffin, W. S. T., & Mattson, M. P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990801)57:3 · Cited by 137 · see citing works
Leyendeckers, H., Odendahl, M., Löhndorf, A., Irsch, J., Spangfort, M. D., Miltenyi, S., Hunzelmann, N., Assenmacher, M., Radbruch, A., & Schmitz, J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199904)29:04 · Cited by 135 · see citing works
Impaired capacity for upregulation of MHC class II in tumor‐associated microglia
Schartner, J. M., Hagar, A. R., Handel, M. M. V., Zhang, L., Nadkarni, N. V., & Badie, B. (2005) · Glia · doi:10.1002/glia.20201 · Cited by 134 · see citing works
Modulation of human microglial cell superoxide production by cytokines
Chao, C. C., Hu, S., & Peterson, P. K. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.58.1.65 · Cited by 131 · cited 1× · see citing works
“In addition, the cytotoxic functions of microglia are carried out by release of superoxide radicals and NO into the microenvironment in response to pathogens and cytokine stimulation [54].”
BackgroundMacrophages in experimental and human brain tumors
Morantz, R. A., Wood, G. W., Foster, M., Clark, M., & Gollahon, K. A. (1979) · Journal of neurosurgery · doi:10.3171/jns.1979.50.3.0298 · Cited by 131 · see citing works
Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia
Pender, M. P., & Rist, M. (2001) · Glia · doi:10.1002/glia.1103 · Cited by 131 · see citing works
Upregulation of RANTES Gene Expression in Neuroglia by Japanese Encephalitis Virus Infection
Chen, C., Chen, J., Chen, S., Liao, S., & Raung, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12107-12119.2004 · Cited by 131 · cited 2× · see citing works
“Specifically, cytokines released by activated microglia include interleukin (IL)-1 [39], IL-6 [40] and tumor necrosis factor-alpha (TNF-α) [41], as well as monocyte chemoattractant protein-1 (MCP-1) [42], macrophage inflammatory protein-1 [43, 44] and RANTES [45], and chemokines for lymphocyte recruitment.”
BackgroundDick, A. D., Ford, A. L., Forrester, J. V., & Sedgwick, J. D. (1995) · British Journal of Ophthalmology · doi:10.1136/bjo.79.9.834 · Cited by 129 · cited 2× · see citing works
“These populations of microglial cells take on APC activity by expression of MHC class II molecules [25].”
BackgroundIncreased Morphological Diversity of Microglia in the Activated Hypothalamic Supraoptic Nucleus
Ayoub, A. E., & Salm, A. K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07759.2003 · Cited by 122 · see citing works
Expression of Fas ligand by microglia: possible role in glioma immune evasion
Badie, B., Schartner, J. M., Prabakaran, S., Paul, J. S., & Vorpahl, J. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00361-7 · Cited by 119 · cited 1× · see citing works
“Microglia in intracranial tumors express FASL and inhibition of FASL leads to a dramatic increase in the number of peripheral immune effector cells seen within tumors [69, 96].”
BackgroundKamei, Y., Inagaki, N., Nishizawa, M., Tsutsumi, O., Taketani, Y., & Inagaki, M. (1998) · Glia · doi:10.1002/(sici)1098-1136(199807)23:3 · Cited by 114 · see citing works
Peress, N. S., Fleit, H. B., Perillo, E., Kuljiš, R. O., & Pezzullo, C. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90060-c · Cited by 111 · see citing works
Microglia-derived macrophages in early multiple sclerosis plaques
Li, H., Cuzner, M. L., & Newcombe, J. (1996) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1996.tb00896.x · Cited by 111 · cited 2× · see citing works
“This cooperative enhancement of costimulation between microglia and T cells has been demonstrated in animal models of multiple sclerosis [34].”
BackgroundBadie, B., Schartner, J. M., Klaver, J., & Vorpahl, J. (1999) · Neurosurgery · doi:10.1097/00006123-199905000-00075 · Cited by 109 · see citing works
Trần, Wolz, Egensperger, Kösel, Imai, Bise, Kohsaka, Mehraein, & Graeber (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00120.x · Cited by 94 · cited 1× · see citing works
“Although MHC molecule expression is seen on microglia within glioma tissues [85, 86], they appear deficient in proper antigen presentation [87] for cytotoxic and helper T cell activation.”
BackgroundYang, I., Kremen, T. J., Giovannone, A. J., Paik, E., Odesa, S. K., Prins, R. M., & Liau, L. M. (2004) · Journal of neurosurgery · doi:10.3171/jns.2004.100.2.0310 · Cited by 84 · cited 1× · see citing works
“Within the CNS under resting states, MHC class I and II expression is generally absent or minimally present [3, 57].”
BackgroundSelf-citationThe mononuclear cell infiltrate compared with survival in high-grade astrocytomas
Rossi, M. I., Jones, N., Candy, E., Nicoll, J. A. R., Compton, J. S., Hughes, J. T., Esiri, M. M., Moss, T., Cruz-Sánchez, F. F., & Coakham, H. B. (1989) · Acta Neuropathologica · doi:10.1007/bf00688208 · Cited by 78 · see citing works
Microglia only weakly present glioma antigen to cytotoxic T cells
Flügel, A., Labeur, M. S., Grasbon‐Frodl, E., Kreutzberg, G. W., & Graeber, M. B. (1999) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00020-9 · Cited by 73 · cited 1× · see citing works
“Although MHC molecule expression is seen on microglia within glioma tissues [85, 86], they appear deficient in proper antigen presentation [87] for cytotoxic and helper T cell activation.”
BackgroundCarpentier, A. F. (2003) · Frontiers in bioscience · doi:10.2741/934 · Cited by 72 · cited 4× · see citing works
“For example, Carpentier and colleagues demonstrated long-term survival in animals with glioma using single intratumoral injection of CpG oligodeoxynucleotide, an immuno-stimulatory sequence that signals through TLR9 to induce the production of IFN-α, IFN-β, IL-12, and TNF-α [97, 98].”
BackgroundInfluentialLafuente, J. V., Adan, B., Alkiza, K., Garibi, J., Rossi, M., & Ff, C.-S. (1999) · Journal of Molecular Neuroscience · doi:10.1385/jmn:13:1-2:177 · Cited by 71 · see citing works
Colony stimulating factor-1 expression in human glioma
Alterman, R. L., & Stanley, E. R. (1994) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815350 · Cited by 70 · see citing works
Badie, B., Schartner, J. M., Paul, J. S., Bartley, B., Vorpahl, J., & Preston, J. K. (2000) · Journal of neurosurgery · doi:10.3171/jns.2000.93.4.0634 · Cited by 69 · cited 2× · see citing works
“Flow cytometry studies by Badie and colleagues demonstrated that as many as one-third of cells of glioma tissues express resident microglia markers, consisting of the largest population of immune cells [2].”
BackgroundBaldwin, A. C., & Kielian, T. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.002 · Cited by 69 · cited 1× · see citing works
“These changes in turn decrease the stringency of the blood-brain barrier, allowing entry of soluble factors and peripheral immune cells [46], including macrophages, natural killer cells and lymphocytes [47, 48].”
BackgroundBadie, B., Bartley, B., & Schartner, J. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00350-8 · Cited by 68 · cited 1× · see citing works
“In contrast, the expressions of MHC class II and costimulatory B7 molecules were significantly increased when freshly isolated microglia were cultured in the absence of glioma cells [88].”
BackgroundTakami, S., Nishikawa, H., Minami, M., Nishiyori, A., Sato, M., Akaike, A., & Satoh, M. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00338-8 · Cited by 67 · cited 1× · see citing works
“Specifically, cytokines released by activated microglia include interleukin (IL)-1 [39], IL-6 [40] and tumor necrosis factor-alpha (TNF-α) [41], as well as monocyte chemoattractant protein-1 (MCP-1) [42], macrophage inflammatory protein-1 [43, 44] and RANTES [45], and chemokines for lymphocyte recruitment.”
BackgroundBrändle, D., Bilsborough, J., Rülicke, T., Uyttenhove, C., Boon, T., & den Eynde, B. J. V. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199812)28:12 · Cited by 62 · see citing works
Suzumura, A., Sawada, M., & Marunouchi, T. (1996) · Brain Research · doi:10.1016/0006-8993(95)01535-3 · Cited by 56 · cited 2× · see citing works
“Microglia and local immune suppression by glioma Glioma cells produce anti-inflammatory cytokines such as IL-6 and TGF-β2 and PGE2 along with producing tumor growth promoting cytokines such as IL-1 and bFGF [1, 91].”
BackgroundReactive microglia in dysmyelination and demyelination
Zhang, S., Goetz, B. D., Carré, J., & Duncan, I. D. (2001) · Glia · doi:10.1002/glia.1045 · Cited by 51 · cited 2× · see citing works
“until stimuli from injury, infection or neurodegenerative process activate their transformation into amoeboid phagocytic cells [10, 11].”
BackgroundImplication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen.
Auf, G., Carpentier, A. F., Chen, L., Clanche, C. L., & Delattre, J. (2001) · PubMed · Cited by 50 · see citing works
Kohji, T., & Matsumoto, Y. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00238-1 · Cited by 48 · cited 2× · see citing works
“Microglia in turn also express FAS molecules which, upon binding FASL, leads to their own apoptosis [66].”
BackgroundT-cell apoptosis in human glioblastoma multiforme: Implications for immunotherapy
Walker, D., Chuah, T., Rist, M., & Pender, M. P. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.006 · Cited by 48 · cited 1× · see citing works
“Microglia in intracranial tumors express FASL and inhibition of FASL leads to a dramatic increase in the number of peripheral immune effector cells seen within tumors [69, 96].”
BackgroundCarbonell, W. S., Murase, S., Horwitz, A. F., & Mandell, J. W. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-5 · Cited by 47 · see citing works
Lu, J., Moochhala, S., Kaur, C., & Ling, E. (2001) · Journal of Neurotrauma · doi:10.1089/089771501750170976 · Cited by 45 · cited 1× · see citing works
“These changes in turn decrease the stringency of the blood-brain barrier, allowing entry of soluble factors and peripheral immune cells [46], including macrophages, natural killer cells and lymphocytes [47, 48].”
BackgroundBarnum, S. R. (1999) · Molecular Medicine · doi:10.1007/bf03402070 · Cited by 45 · cited 1× · see citing works
“Upon activation, microglia upregulate opsonic receptors including complement receptors (CR1, CR3, CR4) and Fc gamma receptors (I, II, III), which enhance phagocytic activity by binding to complement components and immunoglobulin fragments respectively [50, 51].”
BackgroundPrat, E., Baron, P., Meda, L., Scarpini, E. A., Galimberti, D., Ardolino, G., Catania, A., & Scarlato, G. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00966-6 · Cited by 44 · cited 1× · see citing works
“MCP-1 is produced by glioma cells, and microglia express a specific MCP-1 receptor, CCR2 [75, 76].”
BackgroundNguyen, K. B., & Pender, M. P. (1998) · Acta Neuropathologica · doi:10.1007/s004010050763 · Cited by 40 · cited 1× · see citing works
“A similar phenomenon is seen in animal models of multiple sclerosis – T cell debris undergoes phagocytosis by microglia [53].”
BackgroundExperimental Gliosarcoma Induces Chemokine Receptor Expression in Rat Brain
Galasso, J. M., Stegman, L. D., Blaivas, M., Harrison, J. K., Ross, B. D., & Silverstein, F. S. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7249 · Cited by 37 · cited 1× · see citing works
“MCP-1 is produced by glioma cells, and microglia express a specific MCP-1 receptor, CCR2 [75, 76].”
BackgroundReaction of microglial cells in human astrocytomas (preliminary report).
Wierzba‐Bobrowicz, T., Kuchna, I., & Matyja, E. (1994) · PubMed · Cited by 37 · see citing works
GM‐CSF and M‐CSF modulate β‐chemokine and HIV‐1 expression in microglia
Si, Q., Cosenza, M., Zhao, M., Goldstein, H., & Lee, S. C. (2002) · Glia · doi:10.1002/glia.10095 · Cited by 35 · see citing works
Local Neurochemicals and Site-Specific Immune Regulation in the CNS
McCluskey, L. P., & Lampson, L. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.3.177 · Cited by 34 · cited 1× · see citing works
“A complex set of interactions exist between local stimulatory and inhibitory signals in shaping microglial responses: while some neurotransmitters like substance P enhance the active phenotype of microglia [30], electrically active neurons inhibit the increase in expression of MHC class II molecules on microglia in re…”
BackgroundSite-specific immune response to implanted gliomas
Proescholdt, M. A., Merrill, M. J., Ikejiri, B. L., Walbridge, S., Akbaşak, A., Jacobson, S., & Oldfield, E. H. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.6.1012 · Cited by 31 · cited 1× · see citing works
“Although MHC molecule expression is seen on microglia within glioma tissues [85, 86], they appear deficient in proper antigen presentation [87] for cytotoxic and helper T cell activation.”
BackgroundCellular immune response in brain tumors.
Streit, W. J. (1994) · PubMed · Cited by 30 · see citing works
Modulation of Fas-Ligand (Fas-L) on human microglial cells: an in vitro study
Frigerio, S., Silei, V., Ciusani, E., Massa, G. A., Lauro, G. M., & Salmaggi, A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00227-1 · Cited by 29 · cited 1× · see citing works
“The FASL expression on microglia has been described in vitro [64, 65] and in mouse models of multiple sclerosis [66].”
BackgroundBrannan, C. A., & Roberts, M. R. (2004) · Glia · doi:10.1002/glia.20066 · Cited by 25 · see citing works
Suzuki, Y., Funakoshi, H., Machide, M., Matsumoto, K., & Nakamura, T. (2008) · Biomedical Research · doi:10.2220/biomedres.29.77 · Cited by 25 · see citing works
Glioma Immunology and Immunotherapy
Parney, I. F., Hao, C., & Petruk, K. C. (2000) · Neurosurgery · doi:10.1227/00006123-200004000-00002 · Cited by 22 · see citing works
Local proliferation of microglia cells in response to neocortical injury in vitro
Eliason, D. A., Cohen, S. A., Baratta, J. L., Yu, J. Z., & Robertson, R. T. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00413-3 · Cited by 20 · cited 1× · see citing works
“In the context of CNS insult or injury, microglia convert to an active phenotype, with increased proliferation [8], motility [9], and phagocytic activity [10, 11], and release cytokines and reactive oxygen species [12].”
BackgroundNakamichi, K., Saiki, M., Sawada, M., Yamamuro, Y., Morimoto, K., & Kurane, I. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03354.x · Cited by 17 · cited 1× · see citing works
“For example, microglia express TLR [22] and initiate innate responses with the production of cytokines, chemokines and nitric oxide (NO) [37, 38].”
BackgroundDifferential microglial regulation in the human spinal cord under normal and pathological conditions
Stoll, M., Capper, D., Dietz, K., Warth, A., Schleich, A., Schlaszus, H., Meyermann, R., & Mittelbronn, M. G. A. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00774.x · Cited by 15 · cited 2× · see citing works
“MHC molecules are generally restricted to microglia in low levels [6, 57, 58].”
BackgroundTonra, J. R., Reiseter, B. S., Kolbeck, R., Nagashima, K., Robertson, R., Keyt, B. A., & Lindsay, R. M. (2001) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20010129)430:1 · Cited by 1 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.164 · Cited by 1,356 · see citing works
Microglial cell origin and phenotypes in health and disease
Saijo, K., & Glass, C. K. (2011) · Nature Reviews Immunology · doi:10.1038/nri3086 · Cited by 1,100 · see citing works
“Regardless of their classification as M2-like or MDSC-like, glioma-associated microglia express low levels of MHC class II molecules, which are required to present tumour-specific antigens to T cell”
BackgroundEmerging therapies for glioblastoma: current state and future directions
Rong, L., Li, N., & Zhang, Z. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02349-7 · Cited by 515 · see citing works
“In adults, microglia account for approximately 10% of CNS cells and maintain a quiescent phenotype in the normal CNS, expressing low levels of MHC molecules and costimulatory molecules [43].”
BackgroundBidirectional Microglia–Neuron Communication in Health and Disease
Szepesi, Z., Manouchehrian, O., Bachiller, S., & Deierborg, T. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00323 · Cited by 459 · see citing works
Veerhuis, R., Nielsen, H. M., & Tenner, A. J. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.003 · Cited by 420 · see citing works
“…immune effector cells and are able to produce cytokines and chemokines as well as to phagocytose up targets upon stimulation (Dong and Benveniste, 2001;Nielsen et al., 2010;Familian et al., 2007;Nielsen et al., 2009;Fraser et al., 2010;Bohlson et al., 2007;Yang et al., 2010;Watabe et al., 1989).”
BackgroundDifferentiation of human and murine induced pluripotent stem cells to microglia-like cells
Pandya, H., Shen, M. J., Ichikawa, D. M., Sedlock, A. B., Choi, Y., Johnson, K. R., Kim, G., Brown, M. A., Elkahloun, A. G., Maric, D., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4534 · Cited by 405 · see citing works
Kmiecik, J., Poli, A., Brons, N. H. C., Waha, A., Eide, G. E., Enger, P. Ø., Zimmer, J., & Chekenya, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.08.013 · Cited by 389 · see citing works
“Several recent studies observed positive correlation of increased numbers of glioma infiltrating lymphocytes with better patients' survival (Yang et al., 2010b; Lohr et al., 2011; Kim et al., 2012), while some older reports describe negative (Safdari et al., 1985) or no correlation (Rossi et al.,…”
The molecular profile of microglia under the influence of glioma
Li, W., & Graeber, M. B. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos116 · Cited by 341 · see citing works
“It is therefore speculated that microglial cells play a role in tumor progression by supporting angiogenesis as well.(19,255) Molecules contributing to glioma growth and invasion.”
BackgroundTumor infiltrating immune cells in gliomas and meningiomas.
Domingues, P., González-Tablas, M., Otero, Á., Pascual, D., Miranda, D., Ruíz, L., Sousa, P., Ciudad, J., Gonçalves, J., Lopes, M. C., et al. (2016) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2015.07.019 · Cited by 258 · see citing works
Dabrowska, S., Andrzejewska, A., Łukomska, B., & Janowski, M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1571-8 · Cited by 302 · see citing works
“Nevertheless, the transformation of M1-type macrophages (CD16+CD32+CD86+) towards M2-type macrophages (CD206+Arginase-1+) is essential for the induction of tissue regenerative processes.”
BackgroundChallenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Wang, X., Guo, G., Guan, H., Yu, Y., Lu, J., & Yu, J. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1085-3 · Cited by 287 · see citing works
Cui, J. G., Li, Y. Y., Zhao, Y., Bhattacharjee, S., & Lukiw, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178848 · Cited by 240 · see citing works
Iraci, N., Leonardi, T., Gessler, F., Vega, B., & Pluchino, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020171 · Cited by 301 · see citing works
“During brain inflammation, T lymphocytes cross the blood–brain barrier (BBB) and directly interact with microglia to recognise antigens and ultimately to mediate a pro-inflammatory response [134].”
BackgroundHarnessing innate immune pathways for therapeutic advancement in cancer
Hu, A.-K., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 265 · see citing works
Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis
Poon, C. C., Sarkar, S., Yong, V. W., & Kelly, J. J. (2017) · Brain · doi:10.1093/brain/aww355 · Cited by 246 · see citing works
The inflammation hypothesis in geriatric depression
Alexopoulos, G. S., & Morimoto, S. S. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2672 · Cited by 225 · see citing works
Bassett, B., Subramaniyam, S., Yang, F., Varney, S., Pan, H., Carneiro, A. M. D., & Chung, C. Y. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.11.009 · Cited by 217 · see citing works
Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells
Sarkar, S., Döring, A., Zemp, F. J., Silva, C., Lun, X. Q., Wang, X., Kelly, J. J., Hader, W. J., Hamilton, M. G., Mercier, P., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3597 · Cited by 202 · see citing works
Zhang, J., Sarkar, S., Cua, R., Zhou, Y., Hader, W. J., & Yong, V. W. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr289 · Cited by 196 · see citing works
Proteoglycans and their roles in brain cancer
Wade, A., Robinson, A. E., Engler, J. R., Petritsch, C. K., James, C. D., & Phillips, J. J. (2013) · FEBS Journal · doi:10.1111/febs.12109 · Cited by 193 · see citing works
Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A. H., Amankulor, N. A., Fujita, M., Ohlfest, J. R., & Okada, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4124 · Cited by 189 · see citing works
“Although glioblastoma is densely infiltrated by microglia/macrophages (19, 46), to our knowledge, our current study is one of the first to characterize the phenotype and function of MDSCs in human gliomas.”
BackgroundResultBoeck, A. D., Ahn, B. Y., D’Mello, C., Lun, X. Q., Menon, S. V., Alshehri, M. M., Szulzewsky, F., Shen, Y., Khan, L., Dang, N. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18569-4 · Cited by 181 · see citing works
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Zhou, K., Shi, L., Wang, Y., Chen, S., & Zhang, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/9238290 · Cited by 175 · see citing works
“[100] I.”
Brain dendritic cells: biology and pathology
D’Agostino, P. M., Gottfried‐Blackmore, A., Anandasabapathy, N., & Bulloch, K. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1018-0 · Cited by 176 · see citing works
da Fonseca, A. C. C., & Badie, B. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/264124 · Cited by 175 · see citing works
“presentation [7], their effector immune function in gliomas”
BackgroundMicroRNA in Glioblastoma: An Overview
Banelli, B., Forlani, A., Allemanni, G., Morabito, A., Pistillo, M. P., & Romani, M. (2017) · International Journal of Genomics · doi:10.1155/2017/7639084 · Cited by 167 · see citing works
“Microglia and astrocytes, along with macrophages, are part of the glioma microenvironment, astrocytes are part of the brain immune system as they express cytokines and chemokines, and glioma cells produce and are targets of inflammatory molecules [78, 79].”
BackgroundMammana, S., Fagone, P., Cavalli, E., Basile, M. S., Petralia, M. C., Nicoletti, F., Bramanti, P., & Mazzon, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030831 · Cited by 166 · see citing works
“However, once activated, microglia and CNS-infiltrating monocyte-derived macrophages upregulate many surface molecules, including major histocompatibility class II (MCHII) complexes and co-stimulatory molecules, which make them capable of presenting antigens to T cells more efficiently than astrocytes but less efficie…”
BackgroundWaclawiková, B., & El Aidy, S. (2018) · Pharmaceuticals · doi:10.3390/ph11030063 · Cited by 172 · see citing works
Regulation of microglia activation and deactivation by nuclear receptors
Saijo, K., Crotti, A., & Glass, C. K. (2012) · Glia · doi:10.1002/glia.22423 · Cited by 148 · see citing works
“Alternative activation of microglia in the context of brain tumors has been the subject of recent reviews (Charles et al., 2011; Ghosh and Chaudhuri, 2010; Yang et al., 2010).”
BackgroundEvaluating the role of Toll-like receptors in diseases of the central nervous system.
Carty, M., & Bowie, A. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.01.003 · Cited by 154 · see citing works
Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
Jackson, C. M., Ruzevick, J., Phallen, J. A., Belcaid, Z., & Lim, M. K. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/732413 · Cited by 142 · see citing works
“Microglia [14], macrophages, and dendritic cells [15, 16] act as powerful APCs in the CNS.”
BackgroundA review of antibiotics, depression, and the gut microbiome
Hao, W., Li, X., Zhang, P.-W., & Chen, J. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112691 · Cited by 144 · see citing works
Toll-like receptors in cerebral ischemic inflammatory injury
Wang, Y., Lin, S., & Yang, Q. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-134 · Cited by 133 · see citing works
Friend or Foe: S100 Proteins in Cancer
Allgöwer, C., Kretz, A.-L., von Karstedt, S., Wittau, M., Henne‐Bruns, D., & Lemke, J. (2020) · Cancers · doi:10.3390/cancers12082037 · Cited by 131 · see citing works
Yang, I., Han, S. J., Sughrue, M. E., Tihan, T., & Parsa, A. T. (2011) · Journal of neurosurgery · doi:10.3171/2011.4.jns101172 · Cited by 127 · see citing works
Self-citationSTAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications
Kim, J., Patel, M. A., Ruzevick, J., Jackson, C. M., & Lim, M. K. (2014) · Cancers · doi:10.3390/cancers6010376 · Cited by 126 · see citing works
“Several in vitro and in vivo studies of STAT3 inhibitors suggest that STAT3 downregulation can induce cell cycle arrest and apoptosis, often in a dose-dependent manner [77–79].”
BackgroundGlioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma
Alves, T. R., Lima, F. R. S., Kahn, S. A., Lobo, D. S., Dubois, L. G., Soletti, R. C., Borges, H. L., & Moura‐Neto, V. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.04.022 · Cited by 125 · see citing works
“A better understanding regarding the activities of these CNS defense cells is essential in order to establish effective strategies to combat malignant gliomas (Ghosh and Chaudhuri, 2010; Kostianovsky et al., 2008; Yang et al., 2010).”
BackgroundCNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ
Negi, N., & Das, B. K. (2018) · International Reviews of Immunology · doi:10.1080/08830185.2017.1357719 · Cited by 123 · see citing works
“1, CD40, CD80, and CD86 on their surface [36].”
BackgroundRole of AHR and HIF-1α in Glioblastoma Metabolism
Gabriely, G., Wheeler, M. A., Takenaka, M. C., & Quintana, F. J. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.02.009 · Cited by 122 · see citing works
Grace, P. M., Rolan, P. E., & Hutchinson, M. R. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.04.003 · Cited by 114 · see citing works
“…of immunoregulatory molecules such as cellular adhesion molecules, MHC class II and costimulatory molecules that regulate leukocyte infiltration and engagement with APCs (Vass and Lassmann, 1990; Gehrmann et al., 1995; Kreutzberg, 1996; Aloisi, 2001; McCluskey and Lampson, 2001; Yang et al., 2010).”
BackgroundTargeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival
Poli, A., Wang, J., Domingues, O., Planagumà, J., Yan, T., Rygh, C. B., Skaftnesmo, K. O., Thorsen, F. A., McCormack, E., Hentges, F., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1291 · Cited by 115 · see citing works
Sapin, E., Peyron, C., Roche, F., Gay, N., Carcenac, C., Savasta, M., Levy, P. A., & Demattéis, M. (2015) · SLEEP · doi:10.5665/sleep.5042 · Cited by 112 · see citing works
Jeltsch‐David, H., & Muller, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.015 · Cited by 110 · see citing works
“On the other hand, cytokines are produced within the CNS by neurons and microglia, the surveillance cells of the CNS (for a review, see [132]), and take part in the regulation of neurogenesis, cell survival, proliferation and differentiation of new neurons that is crucial for hippocampal functions such as learning and…”
BackgroundTumor Microenvironment in the Brain
Lorger, M. (2012) · Cancers · doi:10.3390/cancers4010218 · Cited by 110 · see citing works
“It has been suggested that upon stimulation, these resident microglia can be rapidly activated via at least two different and functionally distinct morphological states, termed activated and reactive/amoeboid microglia [89,101].”
BackgroundUltrasound in tumor immunotherapy: Current status and future developments
Ho, Y.-J., Li, J.-P., Fan, C., Liu, H.-L., & Yeh, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.04.023 · Cited by 110 · see citing works
Potential therapeutic and pharmacological effects of Wogonin: an updated review
Huynh, D. L., Ngau, T. H., Nguyen, N. H., Tran, G., & Nguyen, C. T. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05972-9 · Cited by 109 · see citing works
Shi, X. (2010) · Cell and Tissue Research · doi:10.1007/s00441-010-1040-2 · Cited by 109 · see citing works
“Perivascular resident macrophages (PVMs) are found in the brain and retina and in other tissues (Cuadros and Navascues 1998; Kezic and McMenamin 2008; Yang et al. 2009, Brigitte et al. 2009; Guth et al. 2009).”
BackgroundIntegrative multi-omics module network inference with lemon-tree
Bonnet, E., Calzone, L., & Michoel, T. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003983 · Cited by 98 · see citing works
“They constitute the dominant form of glioma tumor infiltrating immune cells, and they might promote tumor growth by facilitating immunosuppression of the tumor microenvironment [39].”
Isolation of highly enriched primary human microglia for functional studies
Rustenhoven, J., Park, T. I.-H., Schweder, P., Scotter, J., Correia, J., Smith, A. M., Gibbons, H. M., Oldfield, R. L., Bergin, P. S., Mee, E. W., et al. (2016) · Scientific Reports · doi:10.1038/srep19371 · Cited by 99 · see citing works
Aberrant Expression of Interleukin-1β and Inflammasome Activation in Human Malignant Gliomas
Tarassishin, L., Casper, D., & Lee, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103432 · Cited by 97 · see citing works
Zielinski, M. R., Dunbrasky, D. L., Taishi, P., Souza, G., & Krueger, J. M. (2013) · Sleep · doi:10.5665/sleep.2892 · Cited by 94 · see citing works
The Translational Potential of Microglia and Monocyte-Derived Macrophages in Ischemic Stroke
Wicks, E. E., Ran, K. R., Kim, J. E., Xu, R., Lee, R. P., & Jackson, C. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.897022 · Cited by 92 · see citing works
“In the adult brain, estimates of microglial abundance range from 5-20% (16).”
BackgroundNijaguna, M. B., Patil, V., Urbach, S., Shwetha, S. D., Sravani, K., Hegde, A. S., Chandramouli, B. A., Arivazhagan, A., Marin, P., Santosh, V., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.664037 · Cited by 88 · see citing works
“Moreover, macrophages/microglia has been implicated in glioma pathophysiology (7-9).”
BackgroundArisi, G. M. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.01.017 · Cited by 87 · see citing works
“Microglia are the surveillance cells on the CNS; they are derived not from the neuroectodermal lineage but from the bone marrow (for a review, read [18]).”
Virtuoso, A., Giovannoni, R., Luca, C. D., Gargano, F., Cerasuolo, M., Maggio, N., Lavitrano, M., & Papa, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073301 · Cited by 80 · see citing works
“In the healthy brain, professional macrophages are located around the vessels and in the proximity of the ventricular areas [64], while microglia represents 5–20% of the glial population [65].”
BackgroundBadoer, E. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.07.005 · Cited by 80 · see citing works
Immunotherapy of Primary Brain Tumors: Facts and Hopes
Buerki, R. A., Chheda, Z. S., & Okada, H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2769 · Cited by 80 · see citing works
Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma
Petersen, C. T., & Krenciute, G. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00069 · Cited by 79 · see citing works
CD38 and Regulation of the Immune Response Cells in Cancer
Dwivedi, S., Rendon‐Huerta, E. P., Ortiz-Navarrete, V. F., & Montaño, L. F. (2021) · Journal of Oncology · doi:10.1155/2021/6630295 · Cited by 77 · see citing works
Fu, X., Shen, Y., Wang, W., & Li, X. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12856 · Cited by 79 · see citing works
Isolation of a new cell population in the glioblastoma microenvironment
The Grand Ouest Glioma Project Network, Clavreul, A., Etcheverry, A., Chassevent, A., Quillien, V., Avril, T., Jourdan, M.-L., Michalak, S., François, P., Carré, J., et al. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0701-7 · Cited by 78 · see citing works
“We now have some knowledge of the cancer stem cell biology of GB [10, 11], but, other than for angiogenesis and immune cells, very little is known about the stromal cells of GB [12–14].”
BackgroundDoyon, W. M., Thomas, A. M., Ostroumov, A., Dong, Y., & Dani, J. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.007 · Cited by 77 · see citing works
“During an immune response, foreign stimuli activate macrophages (peripheral) and microglia (central) of the innate immune system to elicit the release of inflammatory cytokines [286].”
Tumor initiating cells induce Cxcr4-mediated infiltration of pro-tumoral macrophages into the brain
Chia, K., Mazzolini, J., Mione, M., & Sieger, D. (2018) · eLife · doi:10.7554/elife.31918 · Cited by 78 · see citing works
“Microglia and infiltrating macrophages have been shown to infiltrate high-grade gliomas and can account for up to 30% of the tumoral mass (Graeber et al., 2002; Badie and Schartner, 2001; Li and Graeber, 2012; Yang et al., 2010; Coniglio and Segall, 2013).”
BackgroundHernangómez, M., Carrillo-Salinas, F. J., Mecha, M., Correa, F., Mestre, L., Loría, F., Feliú, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77 · see citing works
“, [10], in 1919, Ramón y Cajal’s disciple, Pío del Río-Hortega recognised microglial cells as a different cell type from the other glial cells.”
Unique biology of gliomas: challenges and opportunities
Watkins, S., & Sontheimer, H. W. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.05.001 · Cited by 76 · see citing works
Kmiecik, J., Zimmer, J., & Chekenya, M. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1265-5 · Cited by 76 · see citing works
“However, this concept has been revised, as immune cells have been shown to infiltrate brain tumours [4] and play important roles in both anti-tumour immunity [4] and tumour progression [5, 6].”
BackgroundGlioma cell-derived placental growth factor induces regulatory B cells
Han, S. I., Feng, S., Ren, M., Ma, E., Wang, X., Xu, L., & Xu, M. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.005 · Cited by 75 · see citing works
Self-citationDendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
Garzón-Muvdi, T., Theodros, D., Luksik, A. S., Maxwell, R., Kim, E. S., Jackson, C. M., Belcaid, Z., Ganguly, S., Tyler, B., Brem, H., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25061 · Cited by 74 · see citing works
Rahimian, R., Belliveau, C., Chen, R., & Mechawar, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.871997 · Cited by 73 · see citing works
“CB2 receptors are much less expressed in the CNS compared to CB1 receptors, however, they have been found in the brainstem, cerebellum and hippocampus among other areas (212) and are primarily found on immune cells, astrocytes and less commonly in neurons (215).”
BackgroundInfluentialNeonatal Rat Primary Microglia: Isolation, Culturing, and Selected Applications
Ni, M., & Aschner, M. (2010) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx1217s43 · Cited by 73 · see citing works
“A brief list includes studies on the role of microglia in immunity (Yang et al., 2009), protective effects of microglia on co-cultured neurons (Park et al., 2001), modulators of microglial secretion of growth factors (Wang et al., 2009) and cytokines (Ye and Johnson, 1999; Chang, 2007), and the…”
BackgroundIron Oxide as an Mri Contrast Agent for Cell Tracking: Supplementary Issue
Korchinski, D. J., Taha, M., Yang, R., Nathoo, N., & Dunn, J. F. (2015) · Magnetic Resonance Insights · doi:10.4137/mri.s23557 · Cited by 73 · see citing works
do Nascimento, R. P., dos Santos, B. L., Amparo, J. A. O., Soares, J. R. P., da Silva, K. C., de Santana, M. R., Almeida, Á. M. A. N., da Silva, V. D. A., Costa, M. D. F. D., Ulrich, H., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010116 · Cited by 71 · see citing works
Nitric oxide-mediated tumoricidal activity of murine microglial cells
Brantley, E. C., Guo, L., Zhang, C., Lin, Q., Yokoi, K., Langley, R. R., Kruzel, E., Maya, M., Kim, S. W., Kim, S.-J., et al. (2010) · Translational Oncology · doi:10.1593/tlo.10208 · Cited by 71 · see citing works
Wastowski, I. J., Simões, R. T., Yaghi, L., Donadi, E. A., Pancoto, J. A. T., Poras, I., Lechapt, E., Bernaudin, M., Valable, S., Carlotti, C. G., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.10.021 · Cited by 71 · see citing works
The role of STAT3 in tumor-mediated immune suppression
Ferguson, S. D., Srinivasan, V. M., & Heimberger, A. B. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1731-3 · Cited by 70 · see citing works
Glial Cell AMPA Receptors in Nervous System Health, Injury and Disease
Ceprián, M., & Fulton, D. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102450 · Cited by 70 · see citing works
“In addition, microglia express major histocompatibility complex (MHC) I and II molecules, particularly under pathological conditions including perinatal hypoxia, thus a role in the detection of pathological conditions and the stimulation of adaptive immune responses are ascribed to these cells [229].”
BackgroundGhosh, M. K., Chakraborty, D., Sarkar, S., Bhowmik, A., & Basu, M. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0075-4 · Cited by 69 · see citing works
Inhibition of glioma progression by a newly discovered CD38 inhibitor
Blacher, E., Baruch, B. B., Levy, A., Geva, N., Green, K. D., Garneau‐Tsodikova, S., Fridman, M., & Stein, R. (2014) · International Journal of Cancer · doi:10.1002/ijc.29095 · Cited by 69 · see citing works
Mieczkowski, J., Kocyk, M., Nauman, P., Gabrusiewicz, K. R., Sielska, M., Przanowski, P., Maleszewska, M., Rajan, W. D., Pszczolkowska, D., Tykocki, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5310 · Cited by 69 · see citing works
“Type and quality of immune responses in tumor microenvironment are predictive of patient outcome [1].”
Untangling senescent and damage‐associated microglia in the aging and diseased brain
Ng, P. Y., McNeely, T. L., & Baker, D. J. (2023) · The FEBS Journal · doi:10.1111/febs.16315 · Cited by 68 · see citing works
Astrocytes as a target for therapeutic strategies in epilepsy: current insights
Çarçak, N., Onat, F., & Sitnikova, E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183775 · Cited by 69 · see citing works
“, 2020), brain tumors (Yang et al., 2010; Saijo and Glass, 2011), tuberous sclerosis complex (Wong, 2019), encephalopathy (Hamid et al.”
BackgroundInsights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches
Tripathy, D. K., Panda, L. P., Biswal, S., & Barhwal, K. K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1355242 · Cited by 71 · see citing works
Deng, S., Zhu, S., Qiao, Y., Liu, Y., Chen, W., Zhao, G., & Chen, J. (2014) · Protein & Cell · doi:10.1007/s13238-014-0112-6 · Cited by 67 · see citing works
“Furthermore, regarding DCs in vaccines, the most important APCs are artificially derived in an in vitro environment to enhance contact between the cells and the antigens.”
BackgroundInfluentialResistance Mechanisms and Barriers to Successful Immunotherapy for Treating Glioblastoma
Adhikaree, J., Moreno-Vicente, J., Kaur, A. P., Jackson, A. M., & Patel, P. M. (2020) · Cells · doi:10.3390/cells9020263 · Cited by 66 · see citing works
“Microglia release chemoattractants (monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1) when associated with glioma cells promoting further microglial/monocyte recruitment from the peripheral blood and, in combination with the cytokine milieu (IL-10, TGF-β and IL-6), promote further immun…”
BackgroundRole of microglia in fungal infections of the central nervous system
Koutsouras, G. W., Ramos, R. L., & Martinez, L. R. (2016) · Virulence · doi:10.1080/21505594.2016.1261789 · Cited by 64 · see citing works
“cells is continuously being maintained from the periphery, while self-replication characteristics of parenchymal microglia safeguard their maintenance.(11,12,24) In pathological conditions, microglia and perivascular macrophages release chemokines that regulate the”
BackgroundMerighi, S., Bencivenni, S., Vincenzi, F., Varani, K., Borea, P. A., & Gessi, S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.024 · Cited by 65 · see citing works
“4 Discussion Microglia represent a significant fraction of the CNS cells, including 5% to 20% of the total glial population, and are as numerous as neurons [29].”
BackgroundXie, X., Luo, X., Liu, N., Li, X., Lou, F., Zheng, Y., & Ren, Y. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13972 · Cited by 64 · see citing works
“These data strongly suggest the involvement of peripheral immunity dysfunction in the development of PD. Microglia, as the surveillance cell of the CNS, plays a crucial role in regulating brain microenvironment (Yang et al. 2010).”
BackgroundInfluentialJacobs, V. L., Landry, R. P., Liu, Y., Romero-Sandoval, E. A., & Leo, J. A. D. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor194 · Cited by 63 · see citing works
“Once thought to play an antitumor role against established tumors, microglia (central nervous system [CNS] cells of monocytic lineage) are now known to contribute to GBM’s progression and growth.(8) Microglia and macrophages are highly abundant in GBM, compared with normal brain, and provide 10%–34% of the tumor mass.”
BackgroundExtracellular Membrane Vesicles and Immune Regulation in the Brain
Cossetti, C., Smith, J. A., Iraci, N., Leonardi, T., Alfaro‐Cervelló, C., & Pluchino, S. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00117 · Cited by 61 · see citing works
“Once they have been presented with antigens, T cells fulfill a variety of effector functions including pro-inflammatory recruitment, formation of immunological memories, and secretion of cytotoxic molecules (Yang et al., 2010).”
BackgroundCurrent status of gene therapy for brain tumors
Murphy, A. M., & Rabkin, S. D. (2012) · Translational research · doi:10.1016/j.trsl.2012.11.003 · Cited by 62 · see citing works
Hamilton, L., Astell, K. R., Velikova, G., & Sieger, D. (2016) · Zebrafish · doi:10.1089/zeb.2016.1339 · Cited by 61 · see citing works
“Strikingly, a comparable course of events is observed during glioma progression in the brain, where microglia and infiltrating macrophages are attracted to and colonize the tumor.(6,7,9,16,17) However, instead of antitumoral activity they display protumoral functions and promote tumor growth.”
Hypoxia and macrophages promote glioblastoma invasion by the CCL4-CCR5 axis
Wang, Y., Liu, T., Yang, N., Xu, S., Li, X., & Wang, D. (2016) · Oncology Reports · doi:10.3892/or.2016.5171 · Cited by 59 · see citing works
A New Hypothesis for Alzheimer’s Disease: The Lipid Invasion Model
Rudge, J. D. (2022) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-210299 · Cited by 58 · see citing works
“This central role is perhaps unsurprising, given that the “immune-privileged” status conferred on the brain compartment by the BBB leaves microglia as the primary immune cell [242, 243], a role not seen as a rule in macrophages in the rest of the body.”
BackgroundAdvances in NK cell therapy for brain tumors
Fares, J., Davis, Z., Rechberger, J. S., Toll, S. A., Schwartz, J., Daniels, D. J., Miller, J. S., & Khatua, S. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00356-1 · Cited by 67 · see citing works
Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas
de Jesús, M. L., Hostalot, C., Garibi, J., Sallés, J., Meana, J. J., & Callado, L. F. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.03.007 · Cited by 59 · see citing works
“chemoattractants and growth factors by glioma cells (Yang et al., 2010).”
BackgroundPhenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice
Ricard, C., Tchoghandjian, A., Luche, H., Grenot, P., Figarella-Branger, D. F., Rougon, G. N., Malissen, M., & Debarbieux, F. C. (2016) · Scientific Reports · doi:10.1038/srep26381 · Cited by 57 · see citing works
Madhi, I., Kim, J.-H., Shin, J., & Kim, Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12337 · Cited by 56 · see citing works
Nurieva, R., Wang, J., & Sahoo, A. (2013) · Immunotherapy · doi:10.2217/imt.13.33 · Cited by 56 · see citing works
Basic Concepts in Glioma Immunology
Parney, I. F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3146-6_4 · Cited by 56 · see citing works
Levy, A., Blacher, E., Vaknine, H., Lund, F. E., Stein, R., & Mayo, L. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos121 · Cited by 56 · see citing works
“Schartner,(1) Watters, Schartner, and Badie,(3) and Yang et al.(4)).”
Background
- Authors
- Yang, I., Han, S. J., Kaur, G., Crane, C., & Parsa, A. T.
- Affiliations
- University of California, San Francisco (US)
- Venue
- Journal of Clinical Neuroscience
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 17
- Issue
- 1
- Pages
- 6-10
- ISSN
- 0967-5868 (ISSN-L)
- PMC
- PMC3786731
- OpenAlex
- W2161737261
- Cited by
- 410
- References
- 101
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 26 · 2023: 33 · 2022: 41 · 2021: 26 · 2020: 23 · 2019: 24 · 2018: 15 · 2017: 19 · 2016: 22 · 2015: 23 · 2014: 23 · 2013: 27 · 2012: 27
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50CA097257)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- microglia, central nervous system immunity, tumor microenvironment, immunosuppression, antigen presentation, T cell receptor, major histocompatibility complex, antigen-presenting cells, microglial activation, glioma immunotherapy, blood-brain barrier, immune privilege
- MeSH terms
- Animals, Brain Neoplasms, Cell Communication, Central Nervous System, Glioma, Humans, Immune Tolerance, Immunity, Innate, Immunologic Surveillance, Neuroimmunomodulation, Microglia, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review